Avricore Health Inc. (AVCR.V)
| Previous Close | 0.2050 |
| Open | 0.1950 |
| Bid | 0.1900 x 0 |
| Ask | 0.2000 x 0 |
| Day's Range | 0.1850 - 0.1950 |
| 52 Week Range | 0.1350 - 0.4100 |
| Volume | |
| Avg. Volume | 39,488 |
| Market Cap | 18.434M |
| Beta (5Y Monthly) | -2.01 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- News Direct
Avricore Health announces HealthTab now supporting first Rexall Pharmacy walk-in clinic
Avricore Health CEO Hector Bremner joined Steve Darling from Proactive to share news regarding the company's flagship health-data management platform, HealthTab.
- GlobeNewswire
HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic
VANCOUVER, British Columbia, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is expanding its innovative point-of-care chronic and infectious disease screening and health-data management platform, HealthTab™, further into the Canadian pharmacy ecosystem with one of Canada’s largest pharmacy retailers, Rexall Pharmacy Group ULC (“Rexall”). “With Pharmacies’ expanded scope and rising patient demand, the need for the clinical pha
- News Direct
Avricore Health CEO feels company is set up for success with new partnerships and emerging markets
Avricore Health CEO Hector Bremner discussed the company's significant growth, partnerships, and expansion into new markets during an interview with Steve Darling from Proactive.
